COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Aug 3, 2023

Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer

Apr 17, 2023

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases

May 3, 2022

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

Apr 6, 2022

Global Next Generation Complement Therapeutics Markets Report 2022-2035 with Profiles of Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, and UCB

Apr 4, 2022

Next Generation Complement Therapeutics Markets, 2035

For More Press Releases

---